Quick Answer
MEDICURE INC reported Research And Development Expense of $3.08 million for the year ending 2024.
- MEDICURE INC showed an increase of +28.1% in Research And Development Expense from 2023 to 2024.
- This data is from MEDICURE INC's annual report (Form 10-K), filed with the SEC on April 25, 2025.
- XBRL data for this metric is available from 2015 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2015 to 2024), MEDICURE INC's Research And Development Expense has declined by 36.7%.
- Historical annual values: Fiscal year 2024: $3.08 million | Fiscal year 2023: $2.41 million | Fiscal year 2022: $2.75 million | Fiscal year 2021: $1.80 million | Fiscal year 2020: $3.30 million | Fiscal year 2019: $4.35 million | Fiscal year 2018: $6.68 million | Fiscal year 2017: $5.15 million | Fiscal year 2016: $3.63 million | Fiscal year 2015: $4.87 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: